🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pain Phenotypes in Individuals With Chronic Low Back Pain

Recruitingn/aAges 18 Years - 70 YearsAllKutahya Health Sciences University
NCT07766200 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational cross-sectional study aims to determine pain phenotypes in individuals with chronic low back pain (CLBP). Participants will be classified according to a mechanism-based clinical pain phenotyping algorithm as having nociceptive, neuropathic, nociplastic, or mixed pain. Clinical history, quantitative sensory assessment, pain characteristics and distribution, central sensitization-related symptoms, disability, health-related quality of life, and pain catastrophizing will be assessed. In addition, the intra-rater and inter-rater reliability of the pain phenotyping algorithm will be investigated, and the clinical characteristics of different pain phenotypes will be compared.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Low back pain persisting for at least 3 months or present for at least 3 months during the previous 6 months, defined as pain located between the posterior lower costal margins and the inferior gluteal folds * Pain intensity ≥2 on the Numeric Rating Scale * Willingness to participate in the study Exclusion Criteria: * Inability to read and write Turkish * History of lumbar surgery * Presence of a systemic condition affecting sensory function * History of spinal surgery within the previous 6 months or suspected spinal fracture * Inability to complete the study assessments
💊

What it tests

  • Pain classification method
📍

Where

1 site
Kutahya Health Sciences University Physical Medicine and Rehabilitation Department
Kütahya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy